TY  - BOOK
A1  - Bock, Stefanie
A1  - Gauch, Fabian
A1  - Giernat, Yannik
A1  - Hillebrand, Frank
A1  - Kozlova, Darja
A1  - Linck, Lisa
A1  - Moschall, Rebecca
A1  - Sauer, Markus
A1  - Schenk, Christian
A1  - Ulrich, Kristina
A1  - Bodem, Jochen
T1  - HIV-1 : Lehrbuch von Studenten für Studenten
T1  - HIV-1 : a textbook for students written by students
N2  - Dies ist ein Lehrbuch über die HIV-1 Replikation, Pathogenese und Therapie. Es richtet sich an Studenten der Biologie und der Medizin, die etwas mehr über HIV erfahren wollen und stellt neben virologischen Themen auch die zellulären Grundlagen dar. Es umfasst den Viruseintritt, die reverse Transkription, Genom-Integration, Transkriptionsregualtion, die Kotrolle des Spleißens, der Polyadenylierung und des RNA-Exportes. Die Darstellung wird abgerundet mit Kapiteln zum intrazellulärem Transport, zu Nef und zum Virusassembly. In zwei weiteren Kapitel wird die HIV-1 Pathogenese und die Therapie besprochen. Zur Lernkontrolle sind den Kapiteln Fragen und auch Klausurfragen angefügt.
KW  - HIV
KW  - Retroviren
KW  - Lehrbuch
KW  - Viren
KW  - Virologie
KW  - Transkription
KW  - RNS
KW  - Therapie
KW  - Pathogenese
KW  - Epidemiologie
KW  - RNA-Export
KW  - Polyadenylierung
KW  - Reverse Transkription
KW  - Transkription
Y1  - 2013
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-78980
SN  - 978-3-923959-90-7
ER  - 
TY  - JOUR
A1  - Lapa, Constantin
A1  - Kircher, Malte
A1  - Hänscheid, Heribert
A1  - Schirbel, Andreas
A1  - Grigoleit, Götz Ulrich
A1  - Klinker, Erdwine
A1  - Böck, Markus
A1  - Samnick, Samuel
A1  - Pelzer, Theo
A1  - Buck, Andreas K
T1  - Peptide receptor radionuclide therapy as a new tool in treatment-refractory sarcoidosis - initial experience in two patients
JF  - Theranostics
N2  - Sarcoidosis is a multisystem granulomatous disorder of unknown etiology that can involve virtually all organ systems. Whereas most patients present without symptoms, progressive and disabling organ failure can occur in up to 10% of subjects. Somatostatin receptor (SSTR)-directed peptide receptor radionuclide therapy (PRRT) has recently received market authorization for treatment of SSTR-positive neuroendocrine tumors.

Methods: 
We describe the first case series comprising two patients with refractory multi-organ involvement of sarcoidosis who received 4 cycles of PRRT.

Results: 
PRRT was well-tolerated without any acute adverse effects. No relevant toxicities could be recorded during follow-up. Therapy resulted in partial response accompanied by a pronounced reduction in pain (patient #1) and stable disease regarding morphology as well as disease activity (patient #2), respectively.

Conclusion: 
Peptide receptor radionuclide therapy in sarcoidosis is feasible and might be a new valuable tool in patients with otherwise treatment-refractory disease. Given the long experience with and good tolerability of PRRT, further evaluation of this new treatment option for otherwise treatment-refractory sarcoidosis in larger patient cohorts is warranted.
KW  - peptide receptor
KW  - PRRT
KW  - sarcoidosis
KW  - somatostatin receptors
KW  - radionuclide therapy
Y1  - 2018
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-158983
VL  - 8
IS  - 3
ER  -